Role of Parenteral Nutrition in Cancer Patients Undergoing High-Dose Chemotherapy Followed by Autologous Peripheral Blood Progenitor Cell Transplantation
Restricted accessResearch articleFirst published online May, 2005
Role of Parenteral Nutrition in Cancer Patients Undergoing High-Dose Chemotherapy Followed by Autologous Peripheral Blood Progenitor Cell Transplantation
High-dose chemotherapy followed by autologous bone marrow or peripheral blood progenitor cell transplantation represents a recognized option in the treatment of solid tumors and hematologic diseases. Patients receiving high-dose chemotherapy are traditionally supported with parenteral nutrition with the aim to prevent malnutrition secondary to gastrointestinal toxicity and metabolic alterations induced by the conditioning regimens. Nevertheless, well-defined guidelines for its use in this clinical setting are lacking and there are several areas of controversy.
De CiccoM., FantinD.: Nutritional support. Tumori, 5: S63–S67, 2003.
2.
RapoportA.P., Miller WateletL.F., LinderT., EberlyS., RaubertasR., LippJ., DuerstR., AbboudC., ConstineL., AndrewsJ., EtterM.A., SpearL., PowleyE., PackmanC.H., RoweJ.M., SchwertschlagU., BedrosianC., LiesveldJ.L.: Analysis of factors that correlate with mucositis in recipients of autologous and allogenic stem-cell transplants. J Clin Oncol, 17: 2446–2453, 1999.
3.
SonisS.T., OsterG., FuchsH., BellmL., BradfordW.Z., EdelsbergJ., HaydenV., EilersJ., EpsteinJ.B., LevequeF.G., MillerC., PetersonD., SchubertM., SpijkervetF., HorowitzM.: Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol, 19: 2201–2205, 2001.
4.
FilickoJ., LazarusH.M., FlombergN.: Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant, 31: 1–10, 2003.
5.
StiffP.: Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant, 27: S3–11, 2001.
6.
RaynardB., NitenbergG., Gory-DelabaereG., BourhisJ.H., BachmannP., BensadounR.J., DesportJ.C., KereD., SchneiderS., SenesseP., BordigoniP., DieuL.: Summary of the standards, options and recommendations for nutritional support in patients undergoing bone marrow transplantation. Br J Cancer, 89: S101–S106, 2003.
7.
DuguetA., BachmannP., LallemandY., Blanc-VincentM.P.: Summary report of the standards, options and recommendations for malnutrition and nutritional assessment in patients with cancer (1999). Br J Cancer, 89: S92–S97, 2003.
8.
DempseyD.T., MullenJ.L.: Prognostic value of nutritional indices. JPEN, 11: 109S–114S, 1987.
9.
LukaskiH.C.: Requirements for clinical use of bioelectrical impedence analysis (BIA). Ann NY Acad Sci, 873: 72–76, 1999.
10.
ASPEN Board of Directors:Practice guidelines. JPEN, 26: 82SA–83SA, 2002.
11.
American Gastroenterology Association Medical Position Statement:parenteral nutrition. Gastroenterology, 121: 966–969, 2001.
12.
MurrayS.M., PindoriaS.: Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev, 2: CD002920, 2002.
13.
WeisdorfS.A., LysneJ., WindD., HaakeR.J., SharpH.L., GoldmanA., SchisselK., McglaveP.B., RamsayN.K., KerseyJ.H.: Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation, 43: 833–838, 1987.
14.
IestraJ.A., FibbeW.E., ZwindermanA.H., RomijnJ.A., KromhoutD.: Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant, 23: 933–939, 1999.
15.
SzelugaD.J., StuartR.K., BrookmeyerR., UtermohlenV., SantosG.W.: Nutritional support of bone marrow transplant recipients: a prospective, randomised clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res, 47: 3309–3316, 1987.
16.
RobertsS., MillerJ., PineiroL., JenningsL.: Total parenteral nutrition vs oral diet in autologous hematopoietic cell transplant recipients. Bone Marrow Transplant, 32: 715–721, 2003.
17.
MuscaritoliM., GriecoG., CapriaS., IoriA.P., Rossi FanelliF.: Nutritonal and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr, 75: 183–190, 2002.
18.
PylikR., BenesP., PatorkovàM., ChocenskaE., GregoraE., ProchazkaB., KozakT.: Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomised, double-blind, placebo controlled study. Bone Marrow Transplant, 30: 953–961, 2002.
19.
ZieglerT.R.: Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy. J Nutr, 131: 2578S–2584S, 2001.
20.
PiccirilloN., De MatteisS., LaurentiL., ChiusoloP., SoraF., PittirutiM., RutellaS., CicconiS., FioriniA., D'OnofrioG., LeoneG., SicaS.: Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica, 88: 192–200, 2003.
21.
EndresS., GhorbaniR., KelleyV.E., GeorgilisK., LonnemannG., Van der MeerJ.W., CannonJ.G., RogersT.S., KlempnerM.S., WeberP.C.: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med, 320: 321–328, 1989.
22.
KinsellaJ.E., LokeshB., BroughtonS., WhelanJ.: Dietary polyunsaturated fatty acids and eicosanoids; potential effect on the modulation of inflammatory and immune cells: an overview. Nutrition, 5: 24–44, 1990.
23.
BarberM.D., RossJ.A., VossA., TisdaleM.J., FearonK.C.: The effect of oral nutritional supplementation enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer, 81: 80–86, 2001.
